Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

H.G. Gaitán-Duarte, C. Álvarez-Moreno, C.J. Rincón-Rodríguez, N. Yomayusa-González, J.A. Cortés, J.C. Villar, J.S. Bravo-Ojeda, A. García-Peña, W. Adarme-Jaimes, V.A. Rodríguez-Romero, S.L. Villate-Soto, G. Buitrago, J. Chacón-Sarmiento, M. Macias-Quintero, C.P. Vaca, C. Gómez-Restrepo, N. Rodríguez-Malagón

Open source

DOI: 10.1016/j.eclinm.2021.101242
Published: 2022-01
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2021.101242,
  title = {Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial},
  author = {H.G. Gaitán-Duarte and C. Álvarez-Moreno and C.J. Rincón-Rodríguez and N. Yomayusa-González and J.A. Cortés and J.C. Villar and J.S. Bravo-Ojeda and A. García-Peña and W. Adarme-Jaimes and V.A. Rodríguez-Romero and S.L. Villate-Soto and G. Buitrago and J. Chacón-Sarmiento and M. Macias-Quintero and C.P. Vaca and C. Gómez-Restrepo and N. Rodríguez-Malagón},
  year = {2022},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2021.101242},
  url = {https://doi.org/10.1016/j.eclinm.2021.101242}
}

RIS

TY  - JOUR
TI  - Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial
AU  - H.G. Gaitán-Duarte
AU  - C. Álvarez-Moreno
AU  - C.J. Rincón-Rodríguez
AU  - N. Yomayusa-González
AU  - J.A. Cortés
AU  - J.C. Villar
AU  - J.S. Bravo-Ojeda
AU  - A. García-Peña
AU  - W. Adarme-Jaimes
AU  - V.A. Rodríguez-Romero
AU  - S.L. Villate-Soto
AU  - G. Buitrago
AU  - J. Chacón-Sarmiento
AU  - M. Macias-Quintero
AU  - C.P. Vaca
AU  - C. Gómez-Restrepo
AU  - N. Rodríguez-Malagón
PY  - 2022
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2021.101242
UR  - https://doi.org/10.1016/j.eclinm.2021.101242
ER  -

APA

Gaitán-Duarte, H., Álvarez-Moreno, C., Rincón-Rodríguez, C., Yomayusa-González, N., Cortés, J., Villar, J., Bravo-Ojeda, J., García-Peña, A., Adarme-Jaimes, W., Rodríguez-Romero, V., Villate-Soto, S., Buitrago, G., Chacón-Sarmiento, J., Macias-Quintero, M., Vaca, C., Gómez-Restrepo, C., & Rodríguez-Malagón, N. (2022). Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.101242

Source records

crossref · retrieved 2026-09-27T15:44:30.856Z